Introduction of the New Center for Radiopharmaceutical Cancer Research at Helmholtz-Zentrum Dresden-Rossendorf

Abstract A new Center for Radiopharmaceutical Cancer Research was established at the Helmholtz-Zentrum Dresden-Rossendorf in order to centralize radionuclide production, radiopharmaceutical production and the chemical and biochemical research facilities. The newly installed cyclotron is equipped with two beamlines, two target selectors and several liquid, gas and solid target systems. The cyclotron including the target systems and first results of beam characterization measurements as well as results of the radionuclide production are presented. The produced radionuclides are automatically distributed from the targets to the destination hot cells. This process is supervised and controlled by an in-house developed system. View Full-Tex